Piper Jaffray analyst Edward Tenthoff maintains Overweight on Cytokinetics (NASDAQ: CYTK) price target of $13.00.The analyst comments "Today Cytokinetics and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE